CELL AND GENE THERAPY INSIGHTS

Cell therapy clinical translation: ensuring speed to clinic while mitigating risk

Cell therapy clinical translation: ensuring speed to clinic while mitigating risk

Shreya Shukla, Richard Dennett, Steffany Dunn
22 July 2025
Register
Future-proofing gene therapy: scalable AAV solutions and non-viral innovations

Future-proofing gene therapy: scalable AAV solutions and non-viral innovations

Vijetha Bhat
10 July 2025
Register
Learn how to design a simplified, cost-effective LVV manufacturing workflow

Learn how to design a simplified, cost-effective LVV manufacturing workflow

Nicole Votaw, Thomas Robert, Shameer Subratty
08 July 2025
Register
Enabling early AAV characterization: the role of mass photometry in upstream process development

Enabling early AAV characterization: the role of mass photometry in upstream process development

Maria Jacintha Victoria
24 June 2025
Register
AAV production and purification: key steps from design to GMP readiness

AAV production and purification: key steps from design to GMP readiness

Goutham Ganjam, Florian Leseigneur, Emily Jackson-Holmes
11 June 2025
Watch
Leveraging fluid dynamics characterization to accelerate cell therapy product development

Leveraging fluid dynamics characterization to accelerate cell therapy product development

Hamza Patel, Tom Heathman
10 June 2025
Watch
Quickly and accurately measure key analytical attributes of large vectors with the KaritroMP

Quickly and accurately measure key analytical attributes of large vectors with the KaritroMP

Maria Jacintha Victoria
10 June 2025
FastFacts
Optimizing for faster quality control in cell therapies: leveraging rapid detection methods

Optimizing for faster quality control in cell therapies: leveraging rapid detection methods

Srinath Kashi Ranganath
05 June 2025
Watch
To 1000L and beyond: streamlining AAV manufacturing with transfection complex stabilization

To 1000L and beyond: streamlining AAV manufacturing with transfection complex stabilization

Leisha Kopp, Mason Bonitz
03 June 2025
Watch
How do I ensure my early-stage analytical development is ‘phase-appropriate’? Top 5 tips

How do I ensure my early-stage analytical development is ‘phase-appropriate’? Top 5 tips

03 June 2025
Infographic
Find the EV needle in the haystack with Leprechaun

Find the EV needle in the haystack with Leprechaun

Kevin Lance
22 May 2025
Watch
A case study in faster, higher-quality pDNA manufacturing

A case study in faster, higher-quality pDNA manufacturing

Xiangming Gu, Lucas Smith
20 May 2025
Watch
Next-gen immunotherapy: a guide for CGT developers

Next-gen immunotherapy: a guide for CGT developers

Alex Sargent
09 May 2025
EBook
Spot-on, standard-free AAV titer and characterization with Stunner

Spot-on, standard-free AAV titer and characterization with Stunner

Kevin Lance
07 May 2025
Watch
Essential equipment for advancing cell and gene therapy: innovations in incubation, monitoring, and cold storage

Essential equipment for advancing cell and gene therapy: innovations in incubation, monitoring, and cold storage

Tia Harmon
07 May 2025
FastFacts
The path to PAT: the role of process analytical technologies in advancing CAR-T therapy production

The path to PAT: the role of process analytical technologies in advancing CAR-T therapy production

Sarah Rajani
01 May 2025
Interview
Safety assays for quality control of ATMPs: improved mycoplasma detection for cell-based biotherapeutics

Safety assays for quality control of ATMPs: improved mycoplasma detection for cell-based biotherapeutics

Jens Björkman, Andreas Hecker
30 April 2025
Watch
Manufacturing Quality Control for Plasmid DNA Critical Starting Materials

Manufacturing Quality Control for Plasmid DNA Critical Starting Materials

A Frazer, L R. Salvitti, S Lovatt et al
29 April 2025
Watch
A structured approach to addressing leachable risk in cell and gene therapies

A structured approach to addressing leachable risk in cell and gene therapies

Jason Creasey
24 April 2025
Expert Insight
Next-generation sequencing in adventitious agent testing: navigating regulatory acceptance

Next-generation sequencing in adventitious agent testing: navigating regulatory acceptance

Olaf Stamm, Horst Ruppach
15 April 2025
Watch
A path toward universal agreement on fulfilling the need for rapid and reliable sterility assays in gene therapy

A path toward universal agreement on fulfilling the need for rapid and reliable sterility assays in gene therapy

Qin Xiang
14 April 2025
Viewpoint